Cargando…
Therapies targeting the signal pathways of pheochromocytoma and paraganglioma
Pheochromocytoma and paraganglioma (PCC/PGL) are rare tumors that originate from adrenal or extra-adrenal chromaffin cells. A significant clinical manifestation of PCC/PGL is that the tumors release a large number of catecholamines continuously or intermittently, causing persistent or paroxysmal hyp...
Autores principales: | Liu, Yalin, Liu, Longfei, Zhu, Feizhou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6732510/ https://www.ncbi.nlm.nih.gov/pubmed/31564906 http://dx.doi.org/10.2147/OTT.S219056 |
Ejemplares similares
-
Clinical Syndromes and Genetic Screening Strategies of Pheochromocytoma and Paraganglioma
por: Liu, Peihua, et al.
Publicado: (2018) -
Pheochromocytomas and Paragangliomas: From Genetic Diversity to Targeted Therapies
por: Pang, Ying, et al.
Publicado: (2019) -
Pheochromocytomas and secreting paragangliomas
por: Plouin, Pierre-François, et al.
Publicado: (2006) -
Pheochromocytoma and paraganglioma: imaging characteristics
por: Baez, Juan C., et al.
Publicado: (2012) -
Molecular markers of paragangliomas/pheochromocytomas
por: Zhikrivetskaya, Svetlana O, et al.
Publicado: (2017)